BLMH_HUMAN - dbPTM
BLMH_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BLMH_HUMAN
UniProt AC Q13867
Protein Name Bleomycin hydrolase
Gene Name BLMH
Organism Homo sapiens (Human).
Sequence Length 455
Subcellular Localization Cytoplasm.
Protein Description The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity..
Protein Sequence MSSSGLNSEKVAALIQKLNSDPQFVLAQNVGTTHDLLDICLKRATVQRAQHVFQHAVPQEGKPITNQKSSGRCWIFSCLNVMRLPFMKKLNIEEFEFSQSYLFFWDKVERCYFFLSAFVDTAQRKEPEDGRLVQFLLMNPANDGGQWDMLVNIVEKYGVIPKKCFPESYTTEATRRMNDILNHKMREFCIRLRNLVHSGATKGEISATQDVMMEEIFRVVCICLGNPPETFTWEYRDKDKNYQKIGPITPLEFYREHVKPLFNMEDKICLVNDPRPQHKYNKLYTVEYLSNMVGGRKTLYNNQPIDFLKKMVAASIKDGEAVWFGCDVGKHFNSKLGLSDMNLYDHELVFGVSLKNMNKAERLTFGESLMTHAMTFTAVSEKDDQDGAFTKWRVENSWGEDHGHKGYLCMTDEWFSEYVYEVVVDRKHVPEEVLAVLEQEPIILPAWDPMGALAE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MSSSGLNS
-------CCCCCCCH
8.71-
2Phosphorylation------MSSSGLNSE
------CCCCCCCHH
32.9619651622
3Phosphorylation-----MSSSGLNSEK
-----CCCCCCCHHH
27.4219651622
4Phosphorylation----MSSSGLNSEKV
----CCCCCCCHHHH
39.7418491316
10AcetylationSSGLNSEKVAALIQK
CCCCCHHHHHHHHHH
36.6719608861
10UbiquitinationSSGLNSEKVAALIQK
CCCCCHHHHHHHHHH
36.6723000965
17UbiquitinationKVAALIQKLNSDPQF
HHHHHHHHHCCCCCE
42.5129967540
42UbiquitinationDLLDICLKRATVQRA
HHHHHHHHHHHHHHH
35.2621963094
42AcetylationDLLDICLKRATVQRA
HHHHHHHHHHHHHHH
35.2626051181
45PhosphorylationDICLKRATVQRAQHV
HHHHHHHHHHHHHHH
22.6223532336
58PhosphorylationHVFQHAVPQEGKPIT
HHHHHCCCCCCCCCC
27.5632645325
62UbiquitinationHAVPQEGKPITNQKS
HCCCCCCCCCCCCCC
32.2821906983
68UbiquitinationGKPITNQKSSGRCWI
CCCCCCCCCCCCEEE
48.9724816145
184AcetylationMNDILNHKMREFCIR
HHHHHHHHHHHHHHH
38.2826822725
184UbiquitinationMNDILNHKMREFCIR
HHHHHHHHHHHHHHH
38.2824816145
202UbiquitinationLVHSGATKGEISATQ
HHHCCCCCCCCCCCH
54.7521963094
238UbiquitinationFTWEYRDKDKNYQKI
CEEEEECCCCCCCCC
62.7023503661
240UbiquitinationWEYRDKDKNYQKIGP
EEEECCCCCCCCCCC
64.3923503661
244UbiquitinationDKDKNYQKIGPITPL
CCCCCCCCCCCCCHH
38.9921906983
249PhosphorylationYQKIGPITPLEFYRE
CCCCCCCCHHHHHHH
25.59-
259AcetylationEFYREHVKPLFNMED
HHHHHHCCCCCCCCC
37.6026822725
259UbiquitinationEFYREHVKPLFNMED
HHHHHHCCCCCCCCC
37.6021906983
267UbiquitinationPLFNMEDKICLVNDP
CCCCCCCCEEEECCC
23.2429967540
279UbiquitinationNDPRPQHKYNKLYTV
CCCCCCCCCCCCHHH
45.3229967540
279AcetylationNDPRPQHKYNKLYTV
CCCCCCCCCCCCHHH
45.3223749302
280PhosphorylationDPRPQHKYNKLYTVE
CCCCCCCCCCCHHHH
18.53-
282UbiquitinationRPQHKYNKLYTVEYL
CCCCCCCCCHHHHHH
39.5229967540
282AcetylationRPQHKYNKLYTVEYL
CCCCCCCCCHHHHHH
39.5225953088
284PhosphorylationQHKYNKLYTVEYLSN
CCCCCCCHHHHHHHH
15.45-
288PhosphorylationNKLYTVEYLSNMVGG
CCCHHHHHHHHHCCC
15.87-
297UbiquitinationSNMVGGRKTLYNNQP
HHHCCCCCCCCCCCC
46.2723000965
300PhosphorylationVGGRKTLYNNQPIDF
CCCCCCCCCCCCHHH
19.8030576142
309UbiquitinationNQPIDFLKKMVAASI
CCCHHHHHHHHHHHC
38.5221906983
310UbiquitinationQPIDFLKKMVAASIK
CCHHHHHHHHHHHCC
40.5323503661
317UbiquitinationKMVAASIKDGEAVWF
HHHHHHCCCCCEEEE
58.1329967540
330UbiquitinationWFGCDVGKHFNSKLG
EEEEEEHHHHCCCCC
44.8929967540
330AcetylationWFGCDVGKHFNSKLG
EEEEEEHHHHCCCCC
44.8925953088
353PhosphorylationHELVFGVSLKNMNKA
CEEEEEEECCCCCHH
33.7224719451
391UbiquitinationDQDGAFTKWRVENSW
CCCCCEEEEEEECCC
26.9219608861
391AcetylationDQDGAFTKWRVENSW
CCCCCEEEEEEECCC
26.9219608861
420PhosphorylationEWFSEYVYEVVVDRK
HHHHHHCCEEEECCC
11.3418083107

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BLMH_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BLMH_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BLMH_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
UBC9_HUMANUBE2Iphysical
9855622
KBTB7_HUMANKBTBD7physical
16189514
BLMH_HUMANBLMHphysical
16189514
TRIO_HUMANTRIOphysical
16169070
A4_HUMANAPPphysical
10973933
RL11_HUMANRPL11physical
10353821
RL29_HUMANRPL29physical
10353821
BLMH_HUMANBLMHphysical
21163940
TF2AA_HUMANGTF2A1physical
22863883
LZTL1_HUMANLZTFL1physical
22863883
PESC_HUMANPES1physical
22863883
SHLB2_HUMANSH3GLB2physical
22863883
BLMH_HUMANBLMHphysical
25416956
NTAQ1_HUMANWDYHV1physical
25416956
NUD12_HUMANNUDT12physical
25416956
G6PD_HUMANG6PDphysical
26344197
NUD12_HUMANNUDT12physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00290Bleomycin
Regulatory Network of BLMH_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-391, AND MASS SPECTROMETRY.

TOP